Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C15355
◆発行会社(調査会社):MarketLine
◆発行日:2019年3月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Noven Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Noven Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Noven Pharmaceuticals, Inc. (Noven or ‘the company’) develops and sells prescription pharmaceutical products which are marketed under Minivelle, Combipatch and Daytrana brands. These products treat deficit hyperactivity disorder (ADHD), womens diseases and central nervous systems disorders. Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami which are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances. The company is headquartered in Miami, Florida, the US.

Scope

- Detailed information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Noven Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Noven Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Noven Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Noven Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Noven Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Noven Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Noven Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Noven Pharmaceuticals, Inc.: Company Overview
Noven Pharmaceuticals, Inc.: Overview and Key Facts
Noven Pharmaceuticals, Inc.: Overview
Noven Pharmaceuticals, Inc.: Key Facts
Noven Pharmaceuticals, Inc.: Key Employees
Noven Pharmaceuticals, Inc.: Key Employee Biographies
Noven Pharmaceuticals, Inc.: Major Products and Services
Noven Pharmaceuticals, Inc.: Company History
Noven Pharmaceuticals, Inc.: Management Statement
Noven Pharmaceuticals, Inc.: Locations and Subsidiaries
Noven Pharmaceuticals, Inc.: Key Competitors
Noven Pharmaceuticals, Inc.: Company Analysis
Noven Pharmaceuticals, Inc.: Business Description
Noven Pharmaceuticals, Inc.: SWOT Analysis
Noven Pharmaceuticals, Inc.: SWOT Overview
Noven Pharmaceuticals, Inc.: Strengths
Noven Pharmaceuticals, Inc.: Weaknesses
Noven Pharmaceuticals, Inc.: Opportunities
Noven Pharmaceuticals, Inc.: Threats
Noven Pharmaceuticals, Inc.: Recent Developments
Noven Pharmaceuticals, Inc.: News and Events Summary
Noven Pharmaceuticals, Inc.: Business Expansion
Noven Pharmaceuticals, Inc.: Corporate Governance
Noven Pharmaceuticals, Inc.: Regulatory and Legal Events
Noven Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Noven Pharmaceuticals, Inc.: Key Facts
Table 2: Noven Pharmaceuticals, Inc.: Key Employees
Table 3: Noven Pharmaceuticals, Inc.: Company History
Table 4: Noven Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Noven Pharmaceuticals, Inc.: Key Competitors
Table 6: Noven Pharmaceuticals, Inc.: News and Events Summary
Table 7: Noven Pharmaceuticals, Inc.: Business Expansion
Table 8: Noven Pharmaceuticals, Inc.: Corporate Governance
Table 9: Noven Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 10: Noven Pharmaceuticals, Inc.: Strategy and Operations



★海外企業調査レポート[Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Methodist Le Bonheur Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Methodist Le Bonheur Healthcare (Methodist Healthcare) is a healthcare service provider that offers patient care services. The center offers home health services through its hospitals. Its services include invasive spine surgery, education and counseling, cancer treatment and support, infusi …
  • Occidental Petroleum Corp (OXY):石油・ガス:M&Aディール及び事業提携情報
    Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produces oil, …
  • STMicroelectronics NV (STM):企業の財務・戦略的SWOT分析
    STMicroelectronics NV (STM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mutuelle Generale de l’Education Nationale:企業の戦略的SWOT分析
    Mutuelle Generale de l'Education Nationale - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務分析
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • FirstGroup plc (FGP):企業の財務・戦略的SWOT分析
    FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • President Energy PLC (PPC):石油・ガス:M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pargesa Holding SA:企業の戦略・SWOT・財務情報
    Pargesa Holding SA - Strategy, SWOT and Corporate Finance Report Summary Pargesa Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cape plc:企業の戦略・SWOT・財務分析
    Cape plc - Strategy, SWOT and Corporate Finance Report Summary Cape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • MedImmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respi …
  • eNeura Inc-医療機器分野:企業M&A・提携分析
    Summary eNeura Inc (eNeura) formerly eNeura Therapeutics LLC, is a medical device company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device. Its SpringTMS device is pla …
  • Logibec Groupe Informatique Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Logibec Groupe Informatique Ltd (Logibec), a subsidiary of GI Partners LLC, is a technology company that develops, markets, implements and supports clinical and administrative information systems. The company offers administrative solutions include Espresso FMS and MMS, an integrated informa …
  • Medical & Biological Laboratories Co Ltd (4557)-医療機器分野:企業M&A・提携分析
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a provider of clinical and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid synd …
  • ConMed Corp (CNMD):企業の財務・戦略的SWOT分析
    ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Northwest Territories Power Corporation:発電所・企業SWOT分析
    Northwest Territories Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Maruho Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Maruho Co Ltd (Maruho) carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers products for infectious disease, ear n …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆